Figure 1. Research Method Flow Chart 10
Figure 2. Breakdown of Primary Research 12
Figure 3. Bottom-up Approach and Top-down Approach for Market Estimation 14
Figure 4. North America Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2019-2030 16
Figure 5. North America Pharmaceutical Continuous Manufacturing Market, 2019-2030, $ mn 18
Figure 6. Impact of COVID-19 on Business 22
Figure 7. Primary Drivers and Impact Factors of North America Pharmaceutical Continuous Manufacturing Market 24
Figure 8. Primary Restraints and Impact Factors of North America Pharmaceutical Continuous Manufacturing Market 27
Figure 9. Investment Opportunity Analysis 31
Figure 10. Porter’s Fiver Forces Analysis of North America Pharmaceutical Continuous Manufacturing Market 34
Figure 11. Breakdown of North America Pharmaceutical Continuous Manufacturing Market by Product, 2019-2030, % of Sales Revenue 40
Figure 12. North America Addressable Market Cap in 2020-2030 by Product, Value ($ mn) and Share (%) 41
Figure 13. North America Pharmaceutical Continuous Manufacturing Market: Integrated Continuous Systems, 2019-2030, $ mn 42
Figure 14. North America Pharmaceutical Continuous Manufacturing Market: Semi-Continuous Systems, 2019-2030, $ mn 43
Figure 15. North America Pharmaceutical Continuous Manufacturing Market: Continuous Granulators, 2019-2030, $ mn 45
Figure 16. North America Pharmaceutical Continuous Manufacturing Market: Continuous Blenders, 2019-2030, $ mn 46
Figure 17. North America Pharmaceutical Continuous Manufacturing Market: Continuous Compressors, 2019-2030, $ mn 47
Figure 18. North America Pharmaceutical Continuous Manufacturing Market: Continuous Coaters, 2019-2030, $ mn 48
Figure 19. North America Pharmaceutical Continuous Manufacturing Market: Continuous Dryers, 2019-2030, $ mn 49
Figure 20. North America Pharmaceutical Continuous Manufacturing Market: Other Semi-Continuous Systems, 2019-2030, $ mn 50
Figure 21. North America Pharmaceutical Continuous Manufacturing Market: Controls & Software, 2019-2030, $ mn 51
Figure 22. Breakdown of North America Pharmaceutical Continuous Manufacturing Market by Application, 2019-2030, % of Sales Revenue 53
Figure 23. North America Addressable Market Cap in 2020-2030 by Application, Value ($ mn) and Share (%) 53
Figure 24. North America Pharmaceutical Continuous Manufacturing Market: End Product Manufacturing, 2019-2030, $ mn 54
Figure 25. North America Pharmaceutical Continuous Manufacturing Market: Solid Dosage Manufacturing, 2019-2030, $ mn 56
Figure 26. North America Pharmaceutical Continuous Manufacturing Market: Liquid Dosage Manufacturing, 2019-2030, $ mn 57
Figure 27. North America Pharmaceutical Continuous Manufacturing Market: API Manufacturing, 2019-2030, $ mn 58
Figure 28. Breakdown of North America Pharmaceutical Continuous Manufacturing Market by End User, 2019-2030, % of Revenue 61
Figure 29. North America Addressable Market Cap in 2020-2030 by End User, Value ($ mn) and Share (%) 61
Figure 30. North America Pharmaceutical Continuous Manufacturing Market: Pharmaceutical Companies, 2019-2030, $ mn 62
Figure 31. North America Pharmaceutical Continuous Manufacturing Market: Contract Manufacturing Organizations, 2019-2030, $ mn 63
Figure 32. North America Pharmaceutical Continuous Manufacturing Market: Research Organizations and Institutes, 2019-2030, $ mn 64
Figure 33. North America Pharmaceutical Continuous Manufacturing Market: Other End Users, 2019-2030, $ mn 65
Figure 34. Breakdown of North America Pharmaceutical Continuous Manufacturing Market by Country, 2019 and 2030, % of Revenue 67
Figure 35. Contribution to North America 2020-2030 Cumulative Revenue by Country, Value ($ mn) and Share (%) 68
Figure 36. U.S. Pharmaceutical Continuous Manufacturing Market, 2019-2030, $ mn 70
Figure 37. Canada Pharmaceutical Continuous Manufacturing Market, 2019-2030, $ mn 73
Figure 38. Pharmaceutical Continuous Manufacturing Market in Mexico, 2015-2030, $ mn 75
Figure 39. Growth Stage of North America Pharmaceutical Continuous Manufacturing Industry over the Forecast Period 77
North America pharmaceutical continuous manufacturing market is expected to grow by 9.5% annually in the forecast period and reach $851.9 million by 2030 driven by advantages offered by continuous manufacturing process such as cost saving and improved productivity. Highlighted with 25 tables and 39 figures, this 106-page report “North America Pharmaceutical Continuous Manufacturing Market 2020-2030 by Product (Integrated, Semi-Continuous, Controls & Software), Application (End Product, API), End User, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire North America pharmaceutical continuous manufacturing market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2015-2019 and provides forecast from 2020 till 2030 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify North America pharmaceutical continuous manufacturing market in every aspect of the classification from perspectives of Product, Application, End User, and Country. Based on Product, the North America market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section. Integrated Continuous Systems Semi-Continuous Systems • Continuous Granulators • Continuous Blenders • Continuous Compressors • Continuous Coaters • Continuous Dryers • Other Semi-Continuous Systems Controls & Software Based on Application, the North America market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section. End Product Manufacturing • Solid Dosage Manufacturing • Liquid Dosage Manufacturing API Manufacturing Based on End User, the North America market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section. • Pharmaceutical Companies • Contract Manufacturing Organizations • Research Organizations and Institutes • Other End Users Geographically, the following national/local markets are fully investigated: • U.S. • Canada • Mexico Detailed analysis and 2019-2030 annual revenue are available for each key national market. The breakdown of key national markets by Product, Technology, and End User over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Specifically, potential risks associated with investing in North America pharmaceutical continuous manufacturing market are assayed quantitatively and qualitatively through GMD’s Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions. Key Players (this may not be a complete list and extra companies can be added upon request): ACG Group Alexanderwerk Baker Perkins Ltd. Coperion GmbH Fette Compacting Freund-vector Corporation GEA Group AG Gebrüder Lödige Maschinenbau GmbH Gericke AG Glatt GmbH Hosokawa Micron Corporation Korsch AG Leistritz AG Munson Machinery Company, Inc. Powrex Corp Scott Equipment Company Sturtevant, Inc. Thermo Fisher Scientific Inc. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
Read More